Trial Profile
An Open, Randomized, Comparative Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Chorionic gonadotropin
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 11 Mar 2010 New trial record